(SBUX) Starbucks - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US8552441094
Stock: Coffee, Tea, Beverages, Pastries, Sandwiches
Total Rating 43
Risk 58
Buy Signal -0.15
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.65% |
| Yield on Cost 5y | 3.23% |
| Yield CAGR 5y | 7.42% |
| Payout Consistency | 75.0% |
| Payout Ratio | 123.6% |
| Risk 5d forecast | |
|---|---|
| Volatility | 27.7% |
| Relative Tail Risk | -15.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.21 |
| Alpha | -25.20 |
| Character TTM | |
|---|---|
| Beta | 1.044 |
| Beta Downside | 1.338 |
| Drawdowns 3y | |
|---|---|
| Max DD | 35.32% |
| CAGR/Max DD | -0.01 |
Description: SBUX Starbucks January 27, 2026
Starbucks Corp. (NASDAQ:SBUX) is a global coffee roaster, marketer, and retailer operating through three segments-North America, International, and Channel Development. Its store portfolio sells brewed beverages, teas, packaged coffees, food items, and licensed products under brands such as Starbucks Coffee, Teavana, Seattle’s Best, Ethos, and Starbucks Reserve. The company also generates revenue from trademark licensing and sales to grocery and food-service channels.
Key recent metrics (FY 2025, disclosed Oct 2025): revenue of $32.5 billion, comparable-store sales up 5% YoY (North America +4%, International +6%), and an operating margin of 15%. Digital orders now represent roughly 30% of total sales, reflecting the broader restaurant sector’s shift toward online ordering and delivery. Commodity exposure remains a material risk; Arabica coffee prices have risen 12% over the past 12 months, pressuring margins while labor cost inflation in the U.S. continues at ~4% annualized.
For a deeper, data-driven look at Starbucks’ valuation and risk profile, the ValueRay report offers a concise next step.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 1.37b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -1.87 > 1.0 |
| NWC/Revenue: 1.42% < 20% (prev -6.75%; Δ 8.17% < -1%) |
| CFO/TA 0.13 > 3% & CFO 4.27b > Net Income 1.37b |
| Net Debt (30.11b) to EBITDA (5.25b): 5.74 < 3 |
| Current Ratio: 1.05 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.14b) vs 12m ago 0.31% < -2% |
| Gross Margin: 20.60% > 18% (prev 0.26%; Δ 2034 % > 0.5%) |
| Asset Turnover: 117.6% > 50% (prev 113.3%; Δ 4.23% > 0%) |
| Interest Coverage Ratio: 6.03 > 6 (EBITDA TTM 5.25b / Interest Expense TTM 580.4m) |
Altman Z'' -0.27
| A: 0.02 (Total Current Assets 12.02b - Total Current Liabilities 11.49b) / Total Assets 32.23b |
| B: -0.27 (Retained Earnings -8.69b / Total Assets 32.23b) |
| C: 0.11 (EBIT TTM 3.50b / Avg Total Assets 32.06b) |
| D: -0.22 (Book Value of Equity -9.11b / Total Liabilities 40.61b) |
| Altman-Z'' Score: -0.27 = B |
Beneish M -3.08
| DSRI: 0.94 (Receivables 1.22b/1.24b, Revenue 37.70b/36.15b) |
| GMI: 1.26 (GM 20.60% / 26.05%) |
| AQI: 0.69 (AQ_t 0.14 / AQ_t-1 0.21) |
| SGI: 1.04 (Revenue 37.70b / 36.15b) |
| TATA: -0.09 (NI 1.37b - CFO 4.27b) / TA 32.23b) |
| Beneish M-Score: -3.08 (Cap -4..+1) = AA |
What is the price of SBUX shares?
As of February 07, 2026, the stock is trading at USD 99.45 with a total of 8,067,081 shares traded.
Over the past week, the price has changed by +8.16%, over one month by +11.17%, over three months by +21.83% and over the past year by -8.60%.
Over the past week, the price has changed by +8.16%, over one month by +11.17%, over three months by +21.83% and over the past year by -8.60%.
Is SBUX a buy, sell or hold?
Starbucks has received a consensus analysts rating of 3.65.
Therefor, it is recommend to hold SBUX.
- StrongBuy: 9
- Buy: 6
- Hold: 18
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the SBUX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 99.6 | 0.1% |
| Analysts Target Price | 99.6 | 0.1% |
| ValueRay Target Price | 111.1 | 11.7% |
SBUX Fundamental Data Overview February 07, 2026
P/E Trailing = 82.875
P/E Forward = 42.1941
P/S = 3.0053
P/EG = 1.608
Revenue TTM = 37.70b USD
EBIT TTM = 3.50b USD
EBITDA TTM = 5.25b USD
Long Term Debt = 14.58b USD (from longTermDebt, last quarter)
Short Term Debt = 2.84b USD (from shortTermDebt, last quarter)
Debt = 33.52b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 30.11b USD (from netDebt column, last quarter)
Enterprise Value = 143.22b USD (113.30b + Debt 33.52b - CCE 3.60b)
Interest Coverage Ratio = 6.03 (Ebit TTM 3.50b / Interest Expense TTM 580.4m)
EV/FCF = 61.29x (Enterprise Value 143.22b / FCF TTM 2.34b)
FCF Yield = 1.63% (FCF TTM 2.34b / Enterprise Value 143.22b)
FCF Margin = 6.20% (FCF TTM 2.34b / Revenue TTM 37.70b)
Net Margin = 3.63% (Net Income TTM 1.37b / Revenue TTM 37.70b)
Gross Margin = 20.60% ((Revenue TTM 37.70b - Cost of Revenue TTM 29.93b) / Revenue TTM)
Gross Margin QoQ = 15.63% (prev 23.11%)
Tobins Q-Ratio = 4.44 (Enterprise Value 143.22b / Total Assets 32.23b)
Interest Expense / Debt = 0.49% (Interest Expense 165.0m / Debt 33.52b)
Taxrate = 41.09% (1.29b / 3.15b)
NOPAT = 2.06b (EBIT 3.50b * (1 - 41.09%))
Current Ratio = 1.05 (Total Current Assets 12.02b / Total Current Liabilities 11.49b)
Debt / Equity = -4.00 (negative equity) (Debt 33.52b / totalStockholderEquity, last quarter -8.39b)
Debt / EBITDA = 5.74 (Net Debt 30.11b / EBITDA 5.25b)
Debt / FCF = 12.88 (Net Debt 30.11b / FCF TTM 2.34b)
Total Stockholder Equity = -7.95b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.27% (Net Income 1.37b / Total Assets 32.23b)
RoE = -17.22% (negative equity) (Net Income TTM 1.37b / Total Stockholder Equity -7.95b)
RoCE = 52.77% (EBIT 3.50b / Capital Employed (Equity -7.95b + L.T.Debt 14.58b))
RoIC = 24.80% (NOPAT 2.06b / Invested Capital 8.31b)
WACC = 7.60% (E(113.30b)/V(146.82b) * Re(9.76%) + D(33.52b)/V(146.82b) * Rd(0.49%) * (1-Tc(0.41)))
Discount Rate = 9.76% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.06%
[DCF Debug] Terminal Value 77.68% ; FCFF base≈2.57b ; Y1≈2.26b ; Y5≈1.85b
Fair Price DCF = 5.36 (EV 36.21b - Net Debt 30.11b = Equity 6.11b / Shares 1.14b; r=7.60% [WACC]; 5y FCF grow -14.69% → 2.90% )
EPS Correlation: -52.14 | EPS CAGR: -1.38% | SUE: -0.84 | # QB: 0
Revenue Correlation: 79.34 | Revenue CAGR: 7.20% | SUE: 0.72 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.40 | Chg30d=-0.014 | Revisions Net=-7 | Analysts=28
EPS current Year (2026-09-30): EPS=2.28 | Chg30d=-0.082 | Revisions Net=-13 | Growth EPS=+7.1% | Growth Revenue=+3.0%
EPS next Year (2027-09-30): EPS=2.95 | Chg30d=-0.046 | Revisions Net=-8 | Growth EPS=+29.5% | Growth Revenue=+5.4%
P/E Forward = 42.1941
P/S = 3.0053
P/EG = 1.608
Revenue TTM = 37.70b USD
EBIT TTM = 3.50b USD
EBITDA TTM = 5.25b USD
Long Term Debt = 14.58b USD (from longTermDebt, last quarter)
Short Term Debt = 2.84b USD (from shortTermDebt, last quarter)
Debt = 33.52b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 30.11b USD (from netDebt column, last quarter)
Enterprise Value = 143.22b USD (113.30b + Debt 33.52b - CCE 3.60b)
Interest Coverage Ratio = 6.03 (Ebit TTM 3.50b / Interest Expense TTM 580.4m)
EV/FCF = 61.29x (Enterprise Value 143.22b / FCF TTM 2.34b)
FCF Yield = 1.63% (FCF TTM 2.34b / Enterprise Value 143.22b)
FCF Margin = 6.20% (FCF TTM 2.34b / Revenue TTM 37.70b)
Net Margin = 3.63% (Net Income TTM 1.37b / Revenue TTM 37.70b)
Gross Margin = 20.60% ((Revenue TTM 37.70b - Cost of Revenue TTM 29.93b) / Revenue TTM)
Gross Margin QoQ = 15.63% (prev 23.11%)
Tobins Q-Ratio = 4.44 (Enterprise Value 143.22b / Total Assets 32.23b)
Interest Expense / Debt = 0.49% (Interest Expense 165.0m / Debt 33.52b)
Taxrate = 41.09% (1.29b / 3.15b)
NOPAT = 2.06b (EBIT 3.50b * (1 - 41.09%))
Current Ratio = 1.05 (Total Current Assets 12.02b / Total Current Liabilities 11.49b)
Debt / Equity = -4.00 (negative equity) (Debt 33.52b / totalStockholderEquity, last quarter -8.39b)
Debt / EBITDA = 5.74 (Net Debt 30.11b / EBITDA 5.25b)
Debt / FCF = 12.88 (Net Debt 30.11b / FCF TTM 2.34b)
Total Stockholder Equity = -7.95b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.27% (Net Income 1.37b / Total Assets 32.23b)
RoE = -17.22% (negative equity) (Net Income TTM 1.37b / Total Stockholder Equity -7.95b)
RoCE = 52.77% (EBIT 3.50b / Capital Employed (Equity -7.95b + L.T.Debt 14.58b))
RoIC = 24.80% (NOPAT 2.06b / Invested Capital 8.31b)
WACC = 7.60% (E(113.30b)/V(146.82b) * Re(9.76%) + D(33.52b)/V(146.82b) * Rd(0.49%) * (1-Tc(0.41)))
Discount Rate = 9.76% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.06%
[DCF Debug] Terminal Value 77.68% ; FCFF base≈2.57b ; Y1≈2.26b ; Y5≈1.85b
Fair Price DCF = 5.36 (EV 36.21b - Net Debt 30.11b = Equity 6.11b / Shares 1.14b; r=7.60% [WACC]; 5y FCF grow -14.69% → 2.90% )
EPS Correlation: -52.14 | EPS CAGR: -1.38% | SUE: -0.84 | # QB: 0
Revenue Correlation: 79.34 | Revenue CAGR: 7.20% | SUE: 0.72 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.40 | Chg30d=-0.014 | Revisions Net=-7 | Analysts=28
EPS current Year (2026-09-30): EPS=2.28 | Chg30d=-0.082 | Revisions Net=-13 | Growth EPS=+7.1% | Growth Revenue=+3.0%
EPS next Year (2027-09-30): EPS=2.95 | Chg30d=-0.046 | Revisions Net=-8 | Growth EPS=+29.5% | Growth Revenue=+5.4%